Results 261 to 270 of about 23,218 (270)

Post-transcriptional Regulation of Low Density Lipoprotein Receptor Protein by Proprotein Convertase Subtilisin/Kexin Type 9a in Mouse Liver

Journal of Biological Chemistry, 2004
Sahng Wook Park, Young-Ah Moon, Jay D Horton   +2 more
exaly  

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition

Nicholas A. Marston, Marc S. Sabatine
openaire   +1 more source

Pro-protein convertases of subtilisin/kexin family.

Methods in enzymology, 1995
N G, Seidah, M, Chrétien
openaire   +1 more source

Proprotein Convertase Subtilisin/Kexin Type 9 Interacts With Apolipoprotein B and Prevents Its Intracellular Degradation, Irrespective of the Low-Density Lipoprotein Receptor

Arteriosclerosis, Thrombosis, and Vascular Biology, 2012
Ningyan Zhang, Zemin Yao, Ba-Bie Teng
exaly  

[13] Pro-protein convertases of subtilisin/kexin family

1994
Nabil G. Seidah, Michel Chrétien
openaire   +1 more source

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study

Lancet, The, 2012
exaly  

Effect of Alirocumab, a Monoclonal Proprotein Convertase Subtilisin/Kexin 9 Antibody, on Lipoprotein(a) Concentrations (a Pooled Analysis of 150 mg Every Two Weeks Dosing from Phase 2 Trials)

American Journal of Cardiology, 2014
Daniel Gaudet, Daniel Gipe, Henry N Ginsberg   +2 more
exaly  

Regulation of proprotein convertase subtilisin/kexin type 9: Therapeutical perspectives

Atherosclerosis, 2011
openaire   +2 more sources

[Activation of proprotein and kexin-family processing protease].

Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 1998
Y, Matsuda, A, Tsuji
openaire   +1 more source

Protein convertase subtilisin/kexin type 9 in psoriasis

2021
openaire